Viewing nowCombinationPoshvet Duo Extended Release Tablet 10/500 mg
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202204072 · Approved 2022.11.10 · Insurance code 671707210
Improves glycemic control in adults with type 2 diabetes mellitus
This drug helps improve blood glucose control in adult patients with type 2 diabetes who are using dapagliflozin and metformin together. It can be used as an adjunct to dietary and exercise therapies to better manage blood glucose levels. For patients with insufficient blood glucose control among those with cardiovascular disease or risk factors, it is important to refer to expert guidance regarding the cardiovascular effects of dapagliflozin. This drug complements the main therapeutic methods for type 2 diabetes to improve blood glucose control.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as two 5mg/1000mg tablets. Patients who have not previously received pharmacologic treatment for diabetes and for whom adequate glycemic control cannot be achieved with monotherapy: When used as initial therapy in patients who have not previously received pharmacologic treatment for diabetes, the recommended starting dose of this medicine is one 5mg/500mg or 10mg/500mg tablet once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. In patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment may be initiated at the doses of dapagliflozin and metformin previously being taken. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because changes may affect glycemic control, any change in the treatment of patients with type 2 diabetes should be made with careful monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who do not have other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the eGFR falls below 45 mL/min/1.73m2, this medicine must be discontinued immediately. Renal function should be assessed every 3~6 months. Older adults Because metformin is excreted by the kidneys and renal function is more likely to be reduced in older adults, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults, Patient Section).
This drug is used for the treatment of diabetes and should not be administered to patients with impaired kidney function or severe kidney disease. It may very rarely cause a serious metabolic complication known as lactic acidosis, which can be life-threatening, so caution is needed. When used together with insulin or sulfonylurea medications, the risk of hypoglycemia may increase, and dosage adjustments may be necessary in such cases. Patients with reduced fluid volume or at risk of hypotension should be monitored for blood pressure and kidney function while using this drug. This drug may increase the risk of genital and urinary tract infections, so if infection symptoms appear, immediate medical consultation and treatment are required. Pregnant or breastfeeding women should not use this drug, and women who may become pregnant should immediately discontinue use upon confirmation of pregnancy. Older adults may have an increased risk of decreased kidney function, and careful dosage adjustments and regular kidney function tests are necessary. The risk of lactic acidosis may increase when taken with alcohol, so excessive drinking should be avoided while on this medication. Before and after surgery or examinations using iodine contrast agents, this medication should be temporarily discontinued, and kidney function should be checked before re-administration. In overdose situations, appropriate symptomatic treatment is needed, and the metformin component can be removed by dialysis, which may be helpful in emergencies. While taking this medication, if symptoms of hypoglycemia or lactic acidosis such as fatigue, muscle pain, or difficulty breathing occur, inform the doctor immediately, and regular blood tests and kidney function checks are recommended.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also recommended to store it at room temperature between 1°C and 30°C away from direct sunlight.
Pink, oval, biconvex film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationDapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Dapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Poonglim Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Punglim Muhak Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
Dapagliflozin citric acid 7.35mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationDapagliflozin citric acid 14.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
KS Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.